Doctor profile · Federal record
Dr. Amir Larian, M.D.
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Burbank, CA
- NPI 1649467192
- Accepts Medicare
- MIPS 65.3 / 100 · 2023
- 20 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1624 W Olive Ave, Suite B
Burbank, CA 915062459
(818) 729-9149
fax (818) 729-9119
Credentials & registration
- NPI registered
- September 2007 — 19 yrs on file
- Profile last updated
- March 14, 2017
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- California #A118659 · New York #245596
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649467192. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,062
Distinct HCPCS
10
Medicare allowed
$138,723
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 781 | 108 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 373 | 218 | $97 | |
17110 |
Destruction of skin growth, 1-14 growths | 225 | 152 | $127 | |
17000 |
Destruction of precancer skin growth, 1 growth | 221 | 144 | $58 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 159 | 108 | $62 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 86 | 47 | $190 | |
17111 |
Destruction of skin growth, 15 or more growths | 41 | 34 | $139 | |
11102 |
Biopsy of related skin growth, first growth | 36 | 35 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 34 | 25 | $139 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | 13 | $1 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 140. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$1,742
Transactions
64
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 32 | $664.79 | |
| GENZYME CORPORATION | 5 | $241.29 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $152.03 | |
| Galderma Laboratories, L.P. | 1 | $118.77 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $97.94 | |
| LEO Pharma Inc. | 4 | $93.02 | |
| Lilly USA, LLC | 3 | $85.55 | |
| PFIZER INC. | 4 | $72.85 | |
| Amgen Inc. | 3 | $58.00 | |
| MERZ NORTH AMERICA, INC. | 1 | $46.91 | |
| Arcutis Biotherapeutics, Inc. | 2 | $34.61 | |
| UCB, Inc. | 1 | $28.23 | |
| Novartis Pharmaceuticals Corporation | 1 | $27.12 | |
| Dermavant Sciences, Inc. | 1 | $21.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
274
Patients
182
Total drug cost
$8,084
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 100 | 56 | $2,002 |
| Triamcinolone Acetonide | Generic | 39 | 35 | $355 |
| Mupirocin | Generic | 32 | 23 | $243 |
| Clobetasol Propionate | Generic | 29 | 19 | $2,277 |
| Metronidazole | Generic | 25 | 15 | $1,275 |
| Fluocinonide | Generic | 21 | 20 | $938 |
| Fluorouracil | Generic | 15 | 14 | $945 |
| Prednisone | Generic | 13 | 0 | $47 |
Frequently asked questions
What is Dr. Amir Larian's medical specialty?
Dr. Amir Larian practices Dermatology Physician in Burbank, CA.
Where does Dr. Amir Larian practice?
Dr. Amir Larian practices at 1624 W Olive Ave, Burbank, CA 915062459. Office phone: 8187299149.
What is Dr. Amir Larian's NPI?
Dr. Amir Larian's National Provider Identifier (NPI) is 1649467192, issued by NPPES.
Does Dr. Amir Larian accept Medicare assignment?
Yes. Dr. Amir Larian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amir Larian commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.